News and Updates

Lubrizol and Polyhose open a new medical tubing facility in Chennai, scaling production of high-performance polymer components for global healthcare.

Discover how modern clinical trial activation strategies are accelerating drug development and improving patient access to cutting-edge oncology research.

Lubrizol and Polyhose open a new medical tubing plant in Chennai, boosting global supply chains with high-performance, biocompatible medical materials.

New research confirms DHA fish oil reaches the brain but fails to prevent cognitive decline. Discover why this supplement may not protect against dementia.

The FDA has approved a new over-the-counter naloxone nasal spray, expanding access to life-saving opioid overdose reversal treatment for the general public.

Insulet reports successful clinical results for its next-gen Omnipod 6 AID system, promising improved glycemic control and advanced insulin automation.

MIRA Pharmaceuticals files its Phase 2a protocol for Ketamir-2 with the FDA, aiming to tackle chemotherapy-induced peripheral neuropathy. Learn more here.

Aurobindo Pharma’s subsidiary, Eugia Steriles, has received five US FDA observations following a site inspection. Learn the implications for production.

The UK has set a minimum age of 11 for puberty blocker trials. Learn about the new safety protocols and evidence-based approach to pediatric gender-affirming care.

The FDA has expanded the approval of Skinvive by Juvéderm to treat neck wrinkles. Learn how this hyaluronic acid injectable improves skin smoothness.